Samaneh Kamyabiazar

ORCID: 0000-0003-0170-4133
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • MicroRNA in disease regulation
  • Genomics, phytochemicals, and oxidative stress
  • Bioactive Compounds and Antitumor Agents
  • Genomics and Chromatin Dynamics
  • Cancer, Hypoxia, and Metabolism
  • Eicosanoids and Hypertension Pharmacology
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Cancer Treatment and Pharmacology
  • Protein Degradation and Inhibitors
  • Cancer Research and Treatments
  • Galectins and Cancer Biology
  • GDF15 and Related Biomarkers
  • Macrophage Migration Inhibitory Factor
  • Nuclear Receptors and Signaling
  • DNA Repair Mechanisms
  • Estrogen and related hormone effects
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Cell death mechanisms and regulation
  • Neurogenesis and neuroplasticity mechanisms
  • Protein Tyrosine Phosphatases
  • CAR-T cell therapy research
  • Autophagy in Disease and Therapy

McGill University
2023-2024

McGill University Health Centre
2022

Université du Québec à Montréal
2020-2021

Estrogen-related-receptor α (ERRα) plays a critical role in the transcriptional regulation of cellular bioenergetics and metabolism, perturbations its activity have been associated with metabolic diseases. While several coactivators corepressors ERRα identified to date, knowledge gap remains understanding extent which cooperates coregulators control gene expression. Herein, we mapped primary chromatin-bound interactome mouse liver. RIME (Rapid Immuno-precipitation Mass spectrometry...

10.1016/j.molmet.2024.101925 article EN cc-by-nc Molecular Metabolism 2024-03-26

Dendritic cells (DCs) excel at cross-presenting antigens, but their effectiveness as cancer vaccine is limited. Here, we describe a vaccination approach using mesenchymal stromal (MSCs) engineered to express the immunoproteasome complex (MSC-IPr). Such modification instills efficient antigen cross-presentation abilities associated with enhanced major histocompatibility class I and CD80 expression, de novo production of interleukin-12, higher chemokine secretion. This capacity MSC-IPr highly...

10.1016/j.xcrm.2021.100455 article EN cc-by-nc-nd Cell Reports Medicine 2021-12-01

Abstract Increased understanding of the modulatory pathways controlling CD8 T cell responses has led to formulation successful checkpoint inhibitor-based immunotherapies against cancer. However, their effectiveness is limited a few tumor types, motivating search for novel combinatorial strategies. PTPN1 and PTPN2 are two homologous protein tyrosine phosphatases recently proposed as potent intracellular checkpoints. Furthermore, catalytic domain propitious target small-molecule...

10.1101/2023.04.17.537264 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2023-04-18

We report the discovery, via a unique high-throughput screening strategy, of novel bioactive anticancer compound: Thiol Alkylating Compound Inducing Massive Apoptosis (TACIMA)-218. demonstrate that this molecule engenders apoptotic cell death in genetically diverse murine and human cancer lines, irrespective their p53 status, while sparing normal cells. TACIMA-218 causes oxidative stress absence protective antioxidants normally induced by Nuclear factor erythroid 2-related 2 activation. As...

10.1158/1535-7163.mct-20-0333 article EN Molecular Cancer Therapeutics 2020-10-21

Abstract Objective Estrogen-related-receptor α (ERRα) plays a critical role in the transcriptional regulation of cellular bioenergetics and metabolism, perturbations its activity have been associated with metabolic diseases. While several coactivators corepressors ERRα identified to date, knowledge gap remains understanding extent which cooperates coregulators control gene expression. Herein, we mapped primary chromatin-bound interactome mouse liver. Methods RIME (Rapid Immuno-precipitation...

10.1101/2024.01.02.573907 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2024-01-02

Dendritic cells (DCs) excel at cross-presenting antigens, but their effectiveness as cancer vaccine is limited. Here, we describe an innovative approach using mesenchymal stromal (MSCs) engineered to express the immunoproteasome (IPr) complex (MSC-IPr). Such modification instilled efficient antigen abilities associated with enhanced major histocompatibility (MHC)I and CD80 expression, de novo expression of interleukin-12 along higher chemokine secretion. In addition, cross-presentation...

10.2139/ssrn.3782860 article EN SSRN Electronic Journal 2021-01-01

<div>Abstract<p>We report the discovery, via a unique high-throughput screening strategy, of novel bioactive anticancer compound: <u>T</u>hiol <u>A</u>lkylating <u>C</u>ompound <u>I</u>nducing <u>M</u>assive <u>A</u>poptosis (TACIMA)-218. We demonstrate that this molecule engenders apoptotic cell death in genetically diverse murine and human cancer lines, irrespective their p53 status, while sparing normal...

10.1158/1535-7163.c.6542889.v1 preprint EN 2023-04-03

<div>Abstract<p>We report the discovery, via a unique high-throughput screening strategy, of novel bioactive anticancer compound: <u>T</u>hiol <u>A</u>lkylating <u>C</u>ompound <u>I</u>nducing <u>M</u>assive <u>A</u>poptosis (TACIMA)-218. We demonstrate that this molecule engenders apoptotic cell death in genetically diverse murine and human cancer lines, irrespective their p53 status, while sparing normal...

10.1158/1535-7163.c.6542889 preprint EN 2023-04-03
Coming Soon ...